As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply.

New listing from 1 August 2018

Oratane Cap 10 mg 120                                                                                  Pharmacode 2400286             Schedule price $13.34

Oratane Cap 20 mg 120                                                                                  Pharmacode 2400278             Schedule price $20.49

Incumbent brand

Isotane 10 Cap 10 mg 100                                                                                Pharmacode 2123487            Schedule price $14.96

Isotane 20 Cap 20 mg 100                                                                                Pharmacode 2123495            Schedule price $19.27

Reference pricing will apply to the incumbent from 1 October 2018 and delisting 1 January 2019.

As of the date of this notification ProPharma / PWR cannot accept Isotane 10 or 20 Capsules for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

You MUST manage your stock so that you have ZERO stock at time of reference pricing being 1 October 2018 or have been advised of supplier price change/support earlier. No matter what you must manage your stock accordingly.

Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author